Page 117 - ITPS-8-3

INNOSC Theranostics and
Pharmacological Sciences Cholesteatoma enrichment pathways for drug repurposing

Author contributions dysfunction as a major nutritional and lifestyle target for
healthy aging. Maturitas. 2023;170:51-57.
Conceptualization: Ioannis M. Vlastos, John Hajiioannou
Formal analysis: Ioannis M. Vlastos, Kalliopi Gkouskou, doi: 10.1016/j.maturitas.2023.01.013
Investigation: Mohannad Almomani, Nikolaos Drimalas 8. Yoshikawa M, Kojima H, Wada K, et al. Identification of
Writing – original draft: Ioannis M. Vlastos, Mohannad specific gene expression profiles in fibroblasts derived from
Almomani middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg.
Writing – review & editing: Ioannis M. Vlastos, John 2006;132(7):734-742.
Hajiioannou, Nikolaos Drimalas doi: 10.1001/archotol.132.7.734
Ethics approval and consent to participate 9. Cardenas R, Prinsley P, Philpott C, et al. Whole exome
sequencing study identifies candidate loss of function
Not applicable. variants and locus heterogeneity in familial cholesteatoma.
PLoS One. 2023;18(7):e0272174.
Consent for publication doi: 10.1371/journal.pone.0272174

Not applicable. 10. Tokuriki M, Noda I, Saito T, et al. Gene expression analysis
of human middle ear cholesteatoma using complementary
Availability of data DNA arrays. Laryngoscope. 2003;113(5):808-814.

Data are available from the corresponding author upon doi: 10.1097/00005537-200305000-00008
reasonable request. 11. Macias JD, Gerkin RD, Locke D, Macias MP. Differential

References gene expression in cholesteatoma by DNA chip analysis.
Laryngoscope. 2013;123(7):S1-S21.
1. Bovi C, Luchena A, Bivona R, Borsetto D, Creber N, doi: 10.1002/lary.24176
Danesi G. Recurrence in cholesteatoma surgery: What have
we learnt and where are we going? A narrative review. Acta 12. Lee NK, Cass SP, Gubbels SP, et al. Novel candidate genes
Otorhinolaryngol Ital. 2023;43(Suppl 1):S48-S55. for cholesteatoma in chronic otitis media. Front Genet.
2023;13:1033965.
doi: 10.14639/0392-100X-suppl.1-43-2023-06
doi: 10.3389/fgene.2022.1033965
2. Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint
consensus statements on the definitions, classification 13. Klenke C, Janowski S, Borck D, et al. Identification of novel
and staging of middle ear cholesteatoma. J Int Adv Otol. cholesteatoma-related gene expression signatures using full-
2017;13(1):1-8. genome microarrays. PLoS One. 2012;7(12):e52718.
doi: 10.5152/iao.2017.3363 doi: 10.1371/journal.pone.0052718
3. Schürmann M, Goon P, Sudhoff H. Review of potential 14. Gao J, Tang Q, Zhu X, et al. Long noncoding RNAs
medical treatments for middle ear cholesteatoma. Cell show differential expression profiles and display
Commun Signal. 2022;20(1):148. ceRNA potential in cholesteatoma pathogenesis. Oncol
Rep. 2018;39(2):2091-2100.
doi: 10.1186/s12964-022-00953-w
doi: 10.3892/or.2018.6320
4. Nosengo N. Can you teach old drugs new tricks? Nature.
2016;534(7607):314-316. 15. Kwon KH, Kim SJ, Kim HJ, Jung HH. Analysis of gene
expression profiles in cholesteatoma using oligonucleotide
doi: 10.1038/534314a microarray. Acta Otolaryngol. 2006;126(7):691-697.
5. Jovanovic I, Zivkovic M, Jesic S, Stankovic A. Non-coding doi: 10.1080/00016480500475633
RNA and cholesteatoma. Laryngoscope Investig Otolaryngol.
2022;7(1):60-66. 16. Jovanovic I, Zivkovic M, Djuric T, Stojkovic L, Jesic S,
Stankovic A. Perimatrix of middle ear cholesteatoma:
doi: 10.1002/lio2.728 A granulation tissue with a specific transcriptomic signature.
6. Karatzas E, Baltoumas FA, Aplakidou E, et al. Flame (v2.0): Laryngoscope. 2020;130(8):E220-E227.
Advanced integration and interpretation of functional doi: 10.1002/lary.28084
enrichment results from multiple sources. Bioinformatics.
2023;39(1):btad490. 17. Schönermark M, Mester B, Kempf HG, Bläser J, Tschesche H,
Lenarz T. Expression of matrix-metalloproteinases and their
doi: 10.1093/bioinformatics/btad490 inhibitors in human cholesteatomas. Acta Otolaryngol.
1996;116(3):451-456.
7. Grammatikopoulou MG, Skoufas E, Kanellakis S, et al.
Ageotypes revisited: The brain and central nervous system doi: 10.3109/00016489609137872

Volume 8 Issue 3 (2025) 111 doi: 10.36922/itps.2571